Novel Immunotherapeutic Agents and Small Molecule Antagonists of Signalling Kinases for the Treatment of Metastatic Melanoma

Author： Natarajan Nagendra   Telang Sucheta   Miller Donald   Chesney Jason  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.10, 2011-07, pp. : 1233-1250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small molecule v integrin antagonists: novel anticancer agents

By Kerr J.S.   Slee A.M.   Mousa S.A.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1271-1279

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-01 ,pp. : 1345-1352

Bentham Science Publishers

Access to resources Recommend Favorite

Novel agents in development for the treatment of melanoma

By Tarhini Ahmad A   Agarwala Sanjiv S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 885-892

Informa Healthcare

Access to resources Recommend Favorite

Small molecule antagonists of chemokine receptors as emerging anti-HIV agents

By Mastrolorenzo Antonio   Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1245-1252

Informa Healthcare

Access to resources Recommend Favorite

Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agents

By Saragovi H.U.   Burgess K.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 737-751

Informa Healthcare

Access to resources Recommend Favorite